Institute for Biomedical Technologies, National Research Council, Bari, Italy.
Cell Cycle. 2012 Feb 1;11(3):511-23. doi: 10.4161/cc.11.3.19008.
p53 is a central hub in controlling cell proliferation. To maintain genome integrity in response to cellular stress, p53 directly regulates the transcription of genes involved in cell cycle arrest, DNA repair, apoptosis and/or senescence. An array of post-translational modifications and protein-protein interactions modulates its stability and activities in order to avoid malignant transformation. However, to date it is still not clear how cells decide their own fate in response to different types of stress. We described here that the human TRIM8 protein, a member of the TRIM family, is a new modulator of the p53-mediated tumor suppression mechanism. We showed that under stress conditions, such as UV exposure, p53 induced the expression of TRIM8, which in turn stabilized p53 leading to cell cycle arrest and reduction of cell proliferation through enhancement of CDKN1A (p21) and GADD45 expression. TRIM8 silencing reduced the capacity of p53 to activate genes involved in cell cycle arrest and DNA repair, in response to cellular stress. Concurrently, TRIM8 overexpression induced the degradation of the MDM2 protein, the principal regulator of p53 stability. Co-immunoprecipitation experiments showed that TRIM8 physically interacted with p53, impairing its interaction with MDM2. Altogether, our results reveal a previously unknown regulatory pathway controlling p53 activity and suggest TRIM8 as a novel therapeutic target to enhance p53 tumor suppressor activity.
p53 是控制细胞增殖的中心枢纽。为了响应细胞应激,维持基因组完整性,p53 直接调节参与细胞周期阻滞、DNA 修复、细胞凋亡和/或衰老的基因的转录。一系列翻译后修饰和蛋白-蛋白相互作用调节其稳定性和活性,以避免恶性转化。然而,到目前为止,细胞如何响应不同类型的应激来决定自身命运仍不清楚。我们在这里描述了人类 TRIM8 蛋白,一种 TRIM 家族的成员,是 p53 介导的肿瘤抑制机制的新调节剂。我们表明,在应激条件下,如 UV 暴露,p53 诱导 TRIM8 的表达,TRIM8 反过来稳定 p53,导致细胞周期阻滞和细胞增殖减少,通过增强 CDKN1A(p21)和 GADD45 的表达。TRIM8 沉默降低了 p53 激活细胞周期阻滞和 DNA 修复相关基因的能力,以响应细胞应激。同时,TRIM8 过表达诱导 MDM2 蛋白的降解,MDM2 是 p53 稳定性的主要调节因子。共免疫沉淀实验表明,TRIM8 与 p53 物理相互作用,破坏其与 MDM2 的相互作用。总之,我们的结果揭示了一个以前未知的调节途径,控制 p53 活性,并提示 TRIM8 是增强 p53 肿瘤抑制活性的新的治疗靶点。